FDA Approves Medtronic's Pipeline Flex Aneurysm Device
Saturday, February 7, 2015
Source: Mass Device
Medtronic (NYSE:MDT) said today that the FDA approved the Pipeline Flex embolization device it acquired along with Covidien last month, revealing plans for a limited U.S. release of the brain aneurysm treatment.
The latest iteration of the Pipeline device is designed to treat large and giant aneurysms by preventing blood from flowing into them, according to a press release.